Zenith Flex AAA Endovascular System; Zenith Fenestrated AAA Endovascular Graft (ZFEN); Zenith Iliac Branch (ZBIS)
Cook, Inc. · Decision date Aug 4, 2026
What did the FDA decide?
FDA records P020018/S069 as a supplement to PMA P020018, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 4, 2026.
FDA approval order statement
changes to the supplier of packaging materials
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 4, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P020018/S069
- Regulatory pathway
- PMA supplement
- Applicant
- Cook, Inc.
- Product code
- MIH
- Decision code
- OK30
- Decision date
- Aug 4, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.
- Applicant
- Cook, Inc.
- Product code
- MIH
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P020018. Subsequent supplements may change the device or its indications.
FDA decision timeline
P020018 · Original PMA
ZENITH AAA ENDOVASCULAR GRAFT AND H&L-B ONE-SHOT INTRODUCTINO SYSTEM
P020018/S066 · Related supplement
Zenith Flex AAA Endovascular System and Zenith Iliac Branch
P020018/S067 · Related supplement
Zenith Flex AAA Endovascular Graft Bifurcated Main Body; Zenith Renu AAA Ancillary Graft Converter; Zenith Flex with Spi
P020018/S068 · Related supplement
Zenith (Flex) AAA Endovascular Graft; Zenith Renu AAA Ancillary Graft; Zenith Fenestrated AAA Endovascular Graft
P020018/S069 received
Application receipt date recorded by FDA.
P020018/S069 · FDA decision
30-Day Notice
P020018/S070 · Related supplement
Zenith Fenestrated AAA Endovascular Graft, Zenith Iliac Branch
Timeline entries are records held by MedtechLedger for P020018. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P020018
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Cook, Inc. | PMA approval | May 23, 2003 | FDA | |
| Cook, Inc. | PMA supplement | Mar 9, 2026 | FDA | |
| Cook, Inc. | PMA supplement | Apr 21, 2026 | FDA | |
| Cook, Inc. | PMA supplement | May 21, 2026 | FDA | |
| Cook, Inc. | PMA supplement | Sep 17, 2026 | FDA |
Explore the linked device profile
Other records with product code MIH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
RelayPro Thoracic Stent-Graft Delivery SystemP200045/S025 | Bolton Medical, Inc. | PMA supplement | Oct 28, 2026 | FDA |
| Cook Medical Incorporated | PMA supplement | Aug 4, 2026 | FDA | |
| William Cook Europe Aps | PMA supplement | Aug 4, 2026 | FDA | |
GORE EXCLUDER Conformable AAA EndoprosthesisP200030/S026 | W. L. Gore and Associates, Inc. | PMA supplement | Jul 29, 2026 | FDA |
GORE TAG Thoracic Branch Endoprosthesis Zone 0/1P210032/S026 | W. L. Gore & Associates, Inc. | PMA supplement | Jul 13, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Cook, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 750 Daniels Way, P.O. Box 489, Bloomington, IN, 47402
Sources and methodology
- Original FDA record: P020018/S069
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




